(GYNE) - Upper Genital Tract Infections (Co, 2024)
(GYNE) - Upper Genital Tract Infections (Co, 2024)
(GYNE) - Upper Genital Tract Infections (Co, 2024)
Page 1 of 5
iamphenomenal (BCG) |
○ Not highly pathogenic and the presence of genital ● Abundant WBCs in saline microscopy of vaginal
mycoplasma does not change the clinical secretions
presentation and clinical course of acute PID ● Elevated ESR
○ Both may colonize or persist in the endometrial cavity ● Elevated CRP
after complete recovery from acute PID ● Cervical discharge (mucopurulent)
● Endogenous Aerobic and Anaerobic Flora of the Vagina
○ Most common aerobic organisms: Definitive Diagnostic Criteria
■ Nonhemolytic Streptococcus, E. coli, GBS (Strep. ● Endometrial biopsy with histopathologic evidence of
agalactiae), Coagulase-negative Staphylococcus endometritis
○ Anaerobic organisms predominate over aerobes: ○ Not used as initial tool for diagnosis EXCEPT in Pelvic
Bacteroides spp., Peptostreptococcus, Peptococcus Tuberculosis
● Transvaginal sonography or MRI - thick fluid-filled tubes
Note: Regardless of the initiating event, the microbiology of ○ Earliest/easiest that can be done, more especially
PID should be treated as mixed/polymicrobial. TVS (remember, mahal ang MRI)
● Give broad-spectrum antibiotics to cover all organisms ● Laparoscopic abnormalities consistent with PID (gold
standard)
○ If you suspect PID in a patient, you don’t do
laparoscopy. It should be a “last resort” test, as you
wouldn’t want to subject your patient to anesthetic
risk and a very expensive procedure para sa
“suspected” lang
B. RISK FACTORS
● Age at first intercorse
○ Younger coitarche = more likely to have more sexual D. MANAGEMENT
partners down the line Objectives:
● Multiple partners ● Short-term: elimination of signs and symptoms and
● Lack of contraception eradication of infecting organisms
● Oral contraceptive use ● Long-term: reduction of tubal damage and preservation
● Intrauterine device (IUD) - The increase in risk for PID of fertility capacity
occurs only at the time of insertion and in the first 3 weeks
after placement i. OUTPATIENT THERAPY
● Previous tubal ligation - rare and less severe
● Previous PID - 25% subsequently develop another tubal
infection
● Transcervical penetration with instrumentation
(Iatrogenic) - e.g., Hysteroscopy, D&C
● Virulence factors
C. DIAGNOSIS
Minimum Criteria
Empirical treatment of PID should be initiated in sexually
active young women and others at risk for STIs if the ff. are
present and no other cause(s) for the illness can be identified:
● Uterine (or lower abdominal) tenderness, or
● Adnexal tenderness, or ● Management is the same as that of isolated endometritis
● Cervical motion tenderness ● Reexamine women within 48-72 hrs. of initiating
outpatient therapy
Additional Criteria for Diagnosing PID ● Hospitalization warranted if not responding
Increases the specificity of diagnosis; implies inflammatory in ● Reevaluate 4-6 weeks after therapy to assess resolution
nature of clinical symptoms and establish post-therapy baseline
● Oral Temperature >38℃
● Laboratory documentation of cervical chlamydia (CT) or
gonorrhea (GC) infection
Page 2 of 5
iamphenomenal (BCG)
ii. INPATIENT THERAPY Parenteral to Oral Shift:
Indications for Hospitalizing Patients with Acute PID: Symptoms have diminished and the woman afebrile for 24 hrs.
● Surgical emergencies (e.g., appendicitis) cannot be → switch to oral antibiotics → Doxycycline 100 mg BID x 14
excluded days or Clindamycin 450 mg QID x 14 days (alternative)
● Pregnant patients - not very common
● Patient does not respond clinically to oral antimicrobial E. SHORT-TERM SEQUELAE
therapy ● Perihepatitis
● Patients is unable to follow or tolerate an outpatient oral (Fitz-Hugh-Curtis
regimen syndrome)
● Patient has severe illness, nausea and vomiting, or high ○ “violin-string”
fever adhesions
● Patient has a tuboovarian abscess (TOA) ● Tubo-ovarian Abscess
○ Collection of pus
within a newly
created space
● Tubo-ovarian Complex
○ Collection of pus
within an anatomic
space created by
adherence of
adjacent organs
Abscess cavity → Low level
oxygen tension →
● No Metronidazole because anaerobic coverage is already Predominance of anaerobic organisms
accomplished by Cefotetan and Cefoxitin
● Cefotetan - not available in the PH Treatment:
Regimen A Clindamycin
● Doxycycline + IV Cefoxitin ● Stable in abscess environment
● Advantages: excellent for community-acquired infection ● Possess ability to penetrate human neutrophils
○ Doxycycline and cefoxitin - provide excellent Clindamycin + Aminoglycoside (Gentamicin)
coverage for: ● Standard for treatment of TOA
■ N. gonorrhoeae ● Does not treat Enterococcus (add Ampicillin should this
■ C. trachomatis organism be involved)
■ Penicillinase-producing N. gonorrhoeae
○ Cefoxitin
■ Peptococcus
■ Peptostreptococcus
■ E. coli
● Disadvantage: the two drugs are less than ideal for a
pelvic abscess or anaerobic infections
● Doxycycline should be included in the regimen of follow-up
oral therapy (2 weeks)
Parenteral to Oral shift after Clindamycin-Gentamicin
Regimen B
Regimen:
● Clindamycin + Aminoglycoside (Gentamicin)
● Advantage: excellent coverage for anaerobic infections Without TOA Clindamycin 450 mg QID x 14 days [or]
and facultative gram-negative rods Doxycycline 100 mg BID x 14 days
● Preferred for patients with an abscess (esp. Clindamycin),
With TOA Clindamycin 450 mg QID [or]
IUD-related infection, and pelvic infection after a Metronidazole 500 mg BID x 14 days +
diagnostic or operative procedure Doxycycline 100 mg BID x 14 days
Reassess:
Operative Treatment
● After 3 days of treatment
Indications:
● Continue regimen for at least 24 hours after substantial
● Life-threatening infections
improvement
● Ruptured tuboovarian abscesses
● With no improvement, consider:
● Persistent masses in older women for whom childbearing
○ wrong diagnosis
is not a consideration
○ resistant organism (e.g., enterococcus)
● Removal of a persistent symptomatic mass
○ mixed abscess, or rupture
Procedures:
○ septic thrombophlebitis
● Drainage of cul-de-sac abscess via percutaneous
drainage or a colpotomy incision
Page 3 of 5
iamphenomenal (BCG)
● Unilateral Salphingooophorectomy - removal of one ovary ● Diagnosis is usually not made until a tuboovarian abscess
and uterus on one side is examined by a pathologist
● Total Abdominal Hysterectomy with Bilateral ● Histologic examination: “sulfur granules” with gram (+)
Salpingooophorectomy (TAHBSO) filaments
Page 4 of 5
iamphenomenal (BCG)
● Findings: classic giant cells, granulomas, caseous
necrosis
Laparotomy
● Pelvic TB may not be diagnosed until laparotomy or
celiotomy, when the characteristic changes may be
visualized
● Findings: distal ends of the oviducts remain everted;
“tobacco pouch”
C. TREATMENT
Medical (always mauuna)
● 4 drugs initially
● De-escalate to 2-3 drugs based on culture results
Operative therapy (complication: fistula formation)
● Persistent pelvic mass
● Women with resistant organism (1 month medical therapy
→ unresponsive → do surgery)
● Women older than 40
● women whose endometrial cultures remain positive
MDR TB
● Infection from a strain of MTB that is resistant to 2 or
more agents including INH (Isoniazid)
● Tx: 5 drug regimen
○ 2nd line agents added: Ethionamide, Cycloserine,
Linezolid
● Note: XDR TB - Extensively Drug-resistant TB
Sources:
- Uploaded Moodle ppt (2023)
- Parbs Trans
- Live lecture w/ Dr. Co
Page 5 of 5
iamphenomenal (BCG)